Fast Track is one of four Food and Drug Administration (FDA) approaches to make new drugs available as rapidly as possible:[REF] the others are priority review, breakthrough therapy and accelerated approval.
Fast Track was introduced by the FDA Modernization Act of 1997 [REF].